3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Renal Cell
13
Neoplasm Metastasis
12
Prostatic Neoplasms
9
Neoplasms
7
Glioblastoma
7
Kidney Neoplasms
6
Brain Neoplasms
6
Sarcoma
5
Carcinoma, Hepatocellular
5
Ovarian Neoplasms
4
Lymphoma, Non-Hodgkin
4
Glioma
4
Endometrial Neoplasms
4
Colorectal Neoplasms
4
Central Nervous System Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Advanced Cancer
4
Uterine Cervical Neoplasms
3
Recurrence
3
Pancreatic Neoplasms
3
Oligodendroglioma
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Liver Neoplasms
3
Astrocytoma
3
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Interventions
temsirolimus
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Patients With Advanced or Metastatic Solid Tumors
×
temsirolimus
×
Clear all
NCT02215720
2026-03-20
TORERO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Completed
45 enrolled